Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

Petsoglou Constantinos; Balaggan Kamaljit S.; Dart John K. G.; Bunce Catey; Xing Wen; Ali Robin R.; Tuft Stephen J.

首页> 外文期刊>British journal of ophthalmology >Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

【24h】

Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

机译：沉积贝伐单抗诱导角膜新生血管的回归：试点随机安慰剂受控双掩蔽试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective To evaluate the off-label use of subconjunctival bevacizumab for corneal neovascularisation (CoNV).

机译：目的探讨亚治骨叶虫草的非标签用途，用于角膜新生血管（CNV）。

著录项

来源
《British journal of ophthalmology》 |2013年第1期|共5页
作者
Petsoglou Constantinos; Balaggan Kamaljit S.; Dart John K. G.; Bunce Catey; Xing Wen; Ali Robin R.; Tuft Stephen J.;
展开▼
作者单位

Moorfields Eye Hosp NHS Fdn Trust Dept Cornea London England;

Moorfields Eye Hosp NHS Fdn Trust Dept Cornea London England;

Moorfields Eye Hosp NHS Fdn Trust Dept Cornea London England;

Moorfields Eye Hosp NHS Fdn Trust Dept Cornea London England;

Moorfields Eye Hosp NHS Fdn Trust Dept Cornea London England;

UCL Inst Ophthalmol London England;

Moorfields Eye Hosp NHS Fdn Trust Dept Cornea London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献

1. Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial [J] . Petsoglou Constantinos, Balaggan Kamaljit S., Dart John K. G., British journal of ophthalmology . 2013,第1期

机译：结膜下贝伐单抗诱导角膜新生血管消退：一项由安慰剂对照的双盲试验
2. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin? (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design [J] . Praveen J Patel, Catey Bunce, Adnan Tufail Trials . 2008,第1期

机译：关于Avastin疗效和安全性的随机，双重掩蔽的III / IV期研究。（贝伐单抗）玻璃体腔注射与年龄相关性黄斑变性继发脉络膜新生血管的受试者相比标准疗法的临床试验设计
3. Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial [J] . Kumpu M., Kekkonen R. A., Korpela R., Beneficial Microbe . 2015,第5期

机译：活的和灭活的鼠李糖乳杆菌GG对实验性鼻病毒感冒的影响：随机，双盲，安慰剂对照试验
4. Optimizing Management of Paediatric Diarrhoeal Disease: A Pilot, Factorial, Randomized, Placebo-Controlled Trial of Rapid Enteric Diagnostics and Probiotics [C] . David Goldfarb, Jeffrey Pernica, Andrew Steenhoff, International Molecular Medicine Tri-Conference. . 2016

机译：优化儿科腹泻病管理：快速肠诊断和益生菌的试点，阶乘，随机，安慰剂对照试验
5. A randomised double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design [O] . Praveen J Patel, Catey Bunce, Adnan Tufail 2008

机译：在年龄相关性黄斑变性继发脉络膜新生血管的受试者中与标准疗法相比Avastin®（贝伐单抗）玻璃体内注射的疗效和安全性的随机双盲III / IV期研究：临床试验设计
6. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design [O] . 2008

机译：在年龄相关性黄斑变性继发脉络膜新生血管的受试者中，与标准疗法相比，阿瓦斯汀（贝伐单抗）玻璃体内注射的疗效和安全性的随机，双掩蔽III / IV期研究：临床试验设计

Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomised placebo-controlled double-masked trial

摘要

著录项

相似文献

相关主题

期刊订阅